Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Public ClinicalTrials.gov record NCT00975221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Study identification
- NCT ID
- NCT00975221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- Cinacalcet Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 9, 2010
- Primary completion
- Jul 11, 2012
- Completion
- Dec 20, 2012
- Last update posted
- Oct 16, 2018
2010 – 2012
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Lake Forest | California | 92630 | — |
| Research Site | Lancaster | California | 93534 | — |
| Research Site | Los Gatos | California | 95032 | — |
| Research Site | Mission Viejo | California | 92691 | — |
| Research Site | Orange | California | 92869 | — |
| Research Site | San Diego | California | 92124 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Washington D.C. | District of Columbia | 20010 | — |
| Research Site | Aventura | Florida | 33180 | — |
| Research Site | Clearwater | Florida | 33756 | — |
| Research Site | Jacksonville | Florida | 32204 | — |
| Research Site | Miami | Florida | 33145 | — |
| Research Site | Pembroke Pines | Florida | 33028 | — |
| Research Site | Weston | Florida | 33331 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Kenner | Louisiana | 70065 | — |
| Research Site | New Orleans | Louisiana | 70121 | — |
| Research Site | Detroit | Michigan | 48236 | — |
| Research Site | New York | New York | 10032 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Columbus | Ohio | 43210-1296 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00975221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2018 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00975221 live on ClinicalTrials.gov.